ArticleJournal of fungi (Basel, Switzerland)2023
Advocating for Coccidioidomycosis to Be a Reportable Disease Nationwide in the United States and Encouraging Disease Surveillance across North and South America.
Article in Journal of fungi (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Exposure to Coccidioides spp. and silent infection in Sonora, Mexico: A cross-sectional serological and environmental analysis.Medical mycology · 2026Article
- Intent to Accept a Valley Fever Vaccine for Humans and Dogs and Factors Influencing Intended Uptake: A Cross-Sectional Survey in Two Endemic Regions.Journal of fungi (Basel, Switzerland) · 2026Article
- Coccidioidomycosis Exposure Assessed by Skin Testing and Environmental Factors in Baja California, Mexico.Journal of fungi (Basel, Switzerland) · 2026Article
- Antifungal Resistance Surveillance: Insights From National Mycology Reference Centers and Expert Mycology Laboratories.Open forum infectious diseases · 2026Article
- Drug Discovery and Repurposing forJournal of fungi (Basel, Switzerland) · 2025Review
- Valley Fever Is an Occupational Illness: Let's Get the Data to Prevent It.American journal of industrial medicine · 2025Article
- The Epidemiology of Coccidioidomycosis (Valley fever) and the Disease Ecology ofPathogens (Basel, Switzerland) · 2025Article
- Article
- Article
- Coccidioidomycosis: a growing global concern.The Journal of antimicrobial chemotherapy · 2025Review
- Aeolian sediment in El Paso, Texas: Elevated desert sand deposition rates and dust concentrations, enhanced by drought and urban sources.Atmospheric environment (Oxford, England : 1994) · 2025Article
- Times Matter, the Impact of Convective Dust Events on Air Quality in the Greater Phoenix Area, Arizona.GeoHealth · 2025Article
- From soil to clinic: current advances in understandingMicrobiology and molecular biology reviews : MMBR · 2024Review
- Suspected Acute Pulmonary Coccidioidomycosis in Traveler Returning to Switzerland from Peru.Emerging infectious diseases · 2024Article
- Coccidioidomycosis in Immunocompromised at a Non-Endemic Referral Center in Mexico.Journal of fungi (Basel, Switzerland) · 2024Article
- Coccidioidomycosis-Related Hospital Visits, Texas, USA, 2016-2021.Emerging infectious diseases · 2024Review
- Epidemiology of Coccidioidomycosis in the Veterans Health Administration, 2013-2022.Journal of fungi (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Coccidioidomycosis (Valley fever) has been a known health threat in the United States (US) since the 1930s, though not all states are currently required to report disease cases. Texas, one of the non-reporting states, is an example of where both historical and contemporary scientific evidence define the region as endemic, but we don't know disease incidence in the state. Mandating coccidioidomycosis as a reportable disease across more US states would increase disease awareness, improve clinical outcomes, and help antifungal drug and vaccine development. It would also increase our understanding of where the disease is endemic and the relationships between environmental conditions and disease cases. This is true for other nations in North and South America that are also likely endemic for coccidioidomycosis, especially Mexico. This commentary advocates for US state and territory epidemiologists to define coccidioidomycosis as a reportable disease and encourages disease surveillance in other endemic regions across North and South America in order to protect human health and reduce disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.